Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
May 28, 2010
The United States Of America et al v. Amgen, Inc. et al
Case Number:
1:10-cv-02441
Court:
Nature of Suit:
Judge:
Firms
Companies
- Amgen Inc.
- Ascension Health Inc.
- Baxter International Inc.
- Biogen Inc.
- Bristol-Myers Squibb Co.
- Catalent Inc.
- Catholic Health Initiatives
- DaVita Inc.
- Health Management Associates Inc.
- Johnson & Johnson
- Kaiser Permanente
- New England Compounding Pharmacy Inc.
- Novo Nordisk A S
- Sharp Corp.
- Tenet Healthcare Corp.
- Teva Pharmaceutical Industries Ltd.
- Universal Health Services Inc.
- Wedgewood Pharmacy
- West Pharmaceutical Services Inc.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 11, 2016
Merck, Genentech Sold Unapproved Drugs, FCA Suit Says
Merck Serono S.A., Genentech and other drug manufacturers are facing qui tam claims that they illegally received reimbursements from the government for unapproved vaccines and other biologic drugs, according to a False Claims Act suit unsealed Wednesday in New York federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login